Author information:
(1)Department of Oncology, The Affiliated Aoyang Hospital of Jiangsu University, 
Zhangjiagang 215617, China.
(2)Department of Oncology, The Affiliated Aoyang Hospital of Jiangsu University, 
Zhangjiagang 215617, China; Jiangsu University Aoyang Institute of Oncology, 
Zhangjiagang 215617, China.
(3)Department of Oncology, Huai'an Hospital Affiliated of Xuzhou Medical College 
and Huai'an Second People's Hospital, Huai'an 223200, China.
(4)Clinical Biobank, Affiliated Hospital of Nantong University, Nantong 226001, 
China.
(5)Department of Pathology, Nanjing Medical University, Nanjing 210029, China.
(6)Huadong Medical Institute of Biotechniques, Nanjing 210029, China.
(7)The Center for Pathology & Laboratory Medicine, The Affiliated Aoyang 
Hospital of Jiangsu University, Zhangjiagang 215617, China; School of Medicine, 
Jiangsu University, Zhenjiang 212013, China; The Second Affiliated Hospital of 
Nanjing Medical University, Nanjing 210029, China.
(8)Department of Oncology, The Affiliated Aoyang Hospital of Jiangsu University, 
Zhangjiagang 215617, China; Key Laboratory of Antibody Technique of Ministry of 
Health, Nanjing Medical University, Nanjing 210029, China; Collaborative 
Innovation Center for Cancer Personalized Medicine, Jiangsu Key Lab of Cancer 
Biomarkers, Prevention and Treatment, Nanjing Medical University, Nanjing 
210029, China. Electronic address: fengzhenqing@njmu.edu.cn.
(9)Department of Oncology, The Affiliated Aoyang Hospital of Jiangsu University, 
Zhangjiagang 215617, China; Department of Oncology, Shanghai Ruijin Hospital 
Luwan Branch, Shanghai Jiaotong University, Shanghai 200020, China. Electronic 
address: xia_shangzhou@163.com.